Versant Capital Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.9K | Sell |
1,590
-283
| -15% | -$3.09K | ﹤0.01% | 2015 |
|
|
2026
Q1 | $21.7K | Buy |
1,873
+506
| +37% | +$6.31K | ﹤0.01% | 1776 |
|
|
2025
Q4 | $15.6K | Sell |
1,367
-3,516
| -72% | -$41.3K | ﹤0.01% | 1784 |
|
|
2025
Q3 | $62K | Buy |
4,883
+4,384
| +879% | +$63.6K | 0.01% | 934 |
|
|
2025
Q2 | $7.92K | Buy |
+499
| New | +$7.46K | ﹤0.01% | 1992 |
|
|
2025
Q1 | – | Sell |
-15
| Closed | -$285 | – | 2633 |
|
|
2024
Q4 | $285 | Sell |
15
-657
| -98% | -$13.9K | ﹤0.01% | 2315 |
|
|
2024
Q3 | $18.2K | Buy |
672
+252
| +60% | +$6.43K | ﹤0.01% | 835 |
|
|
2024
Q2 | $10.5K | Buy |
420
+355
| +546% | +$10.2K | ﹤0.01% | 966 |
|
|
2024
Q1 | $2.16K | Hold |
65
| – | – | ﹤0.01% | 1324 |
|
|
2023
Q4 | $2.31K | Buy |
65
+36
| +124% | +$1.14K | ﹤0.01% | 1243 |
|
|
2023
Q3 | $991 | Sell |
29
-77
| -73% | -$2.93K | ﹤0.01% | 1532 |
|
|
2023
Q2 | $4.24K | Buy |
106
+83
| +361% | +$3.3K | ﹤0.01% | 1094 |
|
|
2023
Q1 | $903 | Buy |
+23
| New | +$844 | ﹤0.01% | 1468 |
|
|
2022
Q3 | – | Sell |
-4
| Closed | – | – | 1691 |
|
|
2022
Q2 | $0 | Sell |
4
-5
| -56% | -$202 | ﹤0.01% | 1671 |
|
|
2022
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 1662 |
|
|
2021
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 1377 |
|
|
2021
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1395 |
|
|
2021
Q2 | $1K | Sell |
9
-11
| -55% | -$725 | ﹤0.01% | 1390 |
|
|
2021
Q1 | $1K | Sell |
20
-15
| -43% | -$870 | ﹤0.01% | 1464 |
|
|
2020
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 1285 |
|
|
2020
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 1248 |
|
|
2020
Q2 | $1K | Sell |
35
-34
| -49% | -$1.44K | ﹤0.01% | 1241 |
|
|
2020
Q1 | $2K | Sell |
69
-88
| -56% | -$4.48K | ﹤0.01% | 1065 |
|
|
2019
Q4 | $8K | Buy |
157
+55
| +54% | +$3.07K | ﹤0.01% | 794 |
|
|
2019
Q3 | $5K | Buy |
102
+15
| +17% | +$806 | ﹤0.01% | 975 |
|
|
2019
Q2 | $5K | Sell |
87
-18
| -17% | -$967 | ﹤0.01% | 979 |
|
|
2019
Q1 | $5K | Buy |
105
+74
| +239% | +$3.26K | ﹤0.01% | 1126 |
|
|
2018
Q4 | $1K | Hold |
31
| – | – | ﹤0.01% | 1415 |
|
|
2018
Q3 | $1K | Sell |
31
-8
| -21% | -$333 | ﹤0.01% | 1463 |
|
|
2018
Q2 | $1K | Hold |
39
| – | – | ﹤0.01% | 1446 |
|
|
2018
Q1 | $1K | Sell |
39
-12
| -24% | -$707 | ﹤0.01% | 1427 |
|
|
2017
Q4 | $3K | Sell |
51
-5
| -9% | -$318 | ﹤0.01% | 1278 |
|
|
2017
Q3 | $3K | Sell |
56
-26
| -32% | -$1.55K | ﹤0.01% | 1206 |
|
|
2017
Q2 | $5K | Hold |
82
| – | – | ﹤0.01% | 1067 |
|
|
2017
Q1 | $5K | Hold |
82
| – | – | ﹤0.01% | 1066 |
|
|
2016
Q4 | $4K | Buy |
82
+43
| +110% | +$2.54K | ﹤0.01% | 1089 |
|
|
2016
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 1220 |
|
|
2016
Q2 | $2K | Hold |
39
| – | – | ﹤0.01% | 1184 |
|
|
2016
Q1 | $2K | Sell |
39
-15
| -28% | -$884 | ﹤0.01% | 1171 |
|
|
2015
Q4 | $3K | Buy |
+54
| New | +$3.21K | ﹤0.01% | 1076 |
|
Other funds holding XRAY
YIH
YCM
FCBT
COPPSERS
AWM
MFG
JWWM
Versant Capital Management's XRAY Position: Q2 2026 in Review
Versant Capital Management reduced its Dentsply Sirona (XRAY) stake by 15% in Q2 2026, selling an estimated $3.09K and leaving 1,590 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.
Versant Capital Management first reported a position in XRAY in Q4 2015 and has held it in 40 quarters since. The position peaked at $62K in Q3 2025. 32 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.
- Versant Capital Management held 1,590 shares of Dentsply Sirona worth $16.9K as of Q2 2026.
- Versant Capital Management sold 283 Dentsply Sirona shares in Q2 2026, an estimated $3.09K.
- Dentsply Sirona made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2015 holding.
- Versant Capital Management first reported a position in Dentsply Sirona in Q4 2015 and has held it in 40 quarters since.
- Versant Capital Management's Dentsply Sirona position peaked at $62K in Q3 2025.
- 32 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.